首页 | 本学科首页   官方微博 | 高级检索  
     


Re: the use of botulinum toxin in benign prostatic hyperplasia
Authors:Steven A Kaplan
Affiliation:1. Division of Urologic Surgery, Brigham and Women''s Hospital, Boston, Massachusetts;2. Center for Surgery and Public Health, Brigham and Women''s Hospital, Boston, Massachusetts;3. Dana-Farber Cancer Institute, Boston, Massachusetts;4. Department of Urology, Medical University of South Carolina, Charleston, South Carolina;5. Department of Urology, Georgetown University Hospital, Washington, DC;6. Methodist Hospital, Department of Urology, Weill Cornell Medical College, New York, New York;7. Department of Urology, University of California Los Angeles, Los Angeles, California;1. Department of Urology, Queen''s University, Kingston, Ontario, Canada;2. Pfizer Inc, Sandwich, Kent, United Kingdom;3. Citrus Valley Medical Research, Inc., Glendora, California;4. Service d''Urologie, Hospital Tenon, Paris, France;5. Department of Urology, Medical University of South Carolina, Charleston, South Carolina
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号